FDA Approves Johnson & Johnson’s TECNIS PureSee Intraocular Lens for U.S. Patients With Cataracts

JACKSONVILLE, Fla.—Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract surgery in the United States. The TECNIS PureSee IOL delivers clarity of vision for patients, with 97 percent of them reporting no very bothersome visual disturbances, according to the announcement, and it will be available for patients in the U.S. later this year.